Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Why is it a breakthrough? Only 1 injection per week instead of daily basal insulin Ultra-long duration of action (~7 days) Designed to improve treatment adherence and patient convenience Demonstrates effective glycemic control in clinical studies A significant step forward in patient-centered diabetes care Healthcare innovation continues to reshape the future of patient care, and therapies like Insulin Icodec highlight the importance of advancing treatment options that improve both clinical outcomes and quality of life
For researchers working with tirzepatide from any source, proper refrigeration protocols are essential
Using degraded tirzepatide does not save money
This may lead to changes in urine, such as a stronger odor, different color, or lower volume
GLP-1 injections are backed by extensive clinical research, regulated by the MHRA, and prescribed and monitored by healthcare professionals
See our compliance notice below for details
